Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10206875
Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cancer cells and cancer stem cells
granted -
US 10208100
Angiopoietin-2 specific TIE2 receptor
granted -
US 10208074
Pyrazole compounds and method for making and using the compounds
granted -
US 10208012
Compounds for treating inflammatory and hyperproliferative diseases
granted -
US 10206877
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
granted -
US 10211414
Phosphorescent tetradentate metal complexes having modified emission spectra
granted -
US 10208307
Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases
granted -
US 10209255
Method for identifying a bacterial infection
granted -
US 10208103
Use of HDL-related molecules to treat and prevent proinflammatory conditions
granted -
US 10208081
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
granted -
US 10208075
Pyrazole compounds and method for making and using the compounds
granted -
US 10208089
Modulation of complement activity
granted -
US 10208040
Fused imidazo-piperidine JAK inhibitors
granted -
US 10208016
1-sulfonyl piperidine derivatives as modulators of prokineticin receptors
granted -
US 10208046
Nitrogen-containing heterocyclic compound
granted -
US 10208035
Compounds for inhibiting drug-resistant strains of HIV-1 integrase
granted -
US 10207013
Gadolinium-based contrast agents for sensitive detection of Zn2+ with MRI
granted -
US 10206986
Annexin II variant compositions and methods
granted -
US 10206957
Use of gram negative species to treat atopic dermatitis
granted -
US 10207000
Stable aqueous formulations of adalimumab
granted -
US 10206995
Live attenuated virus vaccines for la crosse virus and other bunyaviridae
granted -
US 10206953
Ameliorating nervous systems disorders
granted -
US 10206913
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
granted -
US 10206932
Natural combination hormone replacement formulations and therapies
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.